Zobrazeno 1 - 2
of 2
pro vyhledávání: '"William Makarowski"'
Autor:
Jacques Caldwell, F. Gilbert McMahon, Michael E. Kuss, Marshall Sack, Jitendra Ganju, Robert Trapp, William Makarowski, Howard Offenberg, Tomas S. Bocanegra, David Lee, Robert J. Noveck, Bernard R. Rubin, Susan R.N. Rush, David Sikes, James M. Ratliff, Arthur L. Weaver
Publikováno v:
Clinical Therapeutics. 18:114-124
This 6-week, multicenter, double-masked, placebo-controlled study compared the efficacy, tolerability, and safety of the recommended starting dose of oxaprozin (1200 mg/d) and a 1500-mg/d dose of nabumetone in the treatment of patients with moderate-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45180532c75f45ae857f0ddd9a6e190
https://doi.org/10.1016/s0149-2918(96)80184-6
https://doi.org/10.1016/s0149-2918(96)80184-6
Autor:
David Sikes, David Lee, Howard Offenberg, Tomas S. Bocanegra, Marshall Sack, William Makarowski, Susan R.N. Rush, Arthur L. Weaver, Robert Trapp, Bernard R. Rubin, F.Gilbert McMahon, Michael E. Kuss, Jitendra Ganju, Jacques Caldwell
Publikováno v:
Clinical Therapeutics. 17:735-745
This multicenter, 6-week, double-blind, placebo-controlled, parallel-group study compared the efficacy and safety of oxaprozin 1200 mg once daily with that of nabumetone 1000 mg once daily in patients with moderate-to-severe osteoarthritis (OA) of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2750217585198352a717d5aa7238a841
https://doi.org/10.1016/0149-2918(95)80050-6
https://doi.org/10.1016/0149-2918(95)80050-6